Cargando…
Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002
BACKGROUND: Bloodstream infections are associated with significant patient morbidity and mortality. Antimicrobial susceptibility patterns should guide the choice of empiric antimicrobial regimens for patients with bacteremia. METHODS: From January to December of 2002, 82,569 bacterial blood culture...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420484/ https://www.ncbi.nlm.nih.gov/pubmed/15134581 http://dx.doi.org/10.1186/1476-0711-3-7 |
_version_ | 1782121482469507072 |
---|---|
author | Karlowsky, James A Jones, Mark E Draghi, Deborah C Thornsberry, Clyde Sahm, Daniel F Volturo, Gregory A |
author_facet | Karlowsky, James A Jones, Mark E Draghi, Deborah C Thornsberry, Clyde Sahm, Daniel F Volturo, Gregory A |
author_sort | Karlowsky, James A |
collection | PubMed |
description | BACKGROUND: Bloodstream infections are associated with significant patient morbidity and mortality. Antimicrobial susceptibility patterns should guide the choice of empiric antimicrobial regimens for patients with bacteremia. METHODS: From January to December of 2002, 82,569 bacterial blood culture isolates were reported to The Surveillance Network (TSN) Database-USA by 268 laboratories. Susceptibility to relevant antibiotic compounds was analyzed using National Committee for Clinical Laboratory Standards guidelines. RESULTS: Coagulase-negative staphylococci (42.0%), Staphylococcus aureus (16.5%), Enterococcus faecalis (8.3%), Escherichia coli (7.2%), Klebsiella pneumoniae (3.6%), and Enterococcus faecium (3.5%) were the most frequently isolated bacteria from blood cultures, collectively accounting for >80% of isolates. In vitro susceptibility to expanded-spectrum β-lactams such as ceftriaxone were high for oxacillin-susceptible coagulase-negative staphylococci (98.7%), oxacillin-susceptible S. aureus (99.8%), E. coli (97.3%), K. pneumoniae (93.3%), and Streptococcus pneumoniae (97.2%). Susceptibilities to fluoroquinolones were variable for K. pneumoniae (90.3–91.4%), E. coli (86.0–86.7%), oxacillin-susceptible S. aureus (84.0–89.4%), oxacillin-susceptible coagulase-negative staphylococci (72.7–82.7%), E. faecalis (52.1%), and E. faecium (11.3%). Combinations of antimicrobials are often prescribed as empiric therapy for bacteremia. Susceptibilities of all blood culture isolates to one or both agents in combinations of ceftriaxone, ceftazdime, cefepime, piperacillin-tazobactam or ciprofloxacin plus gentamicin were consistent (range, 74.8–76.3%) but lower than similar β-lactam or ciprofloxacin combinations with vancomycin (range, 93.5–96.6%). CONCLUSION: Ongoing surveillance for antimicrobial susceptibility remains essential, and will enhance efforts to identify resistance and attempt to limit its spread. |
format | Text |
id | pubmed-420484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-4204842004-06-11 Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 Karlowsky, James A Jones, Mark E Draghi, Deborah C Thornsberry, Clyde Sahm, Daniel F Volturo, Gregory A Ann Clin Microbiol Antimicrob Research BACKGROUND: Bloodstream infections are associated with significant patient morbidity and mortality. Antimicrobial susceptibility patterns should guide the choice of empiric antimicrobial regimens for patients with bacteremia. METHODS: From January to December of 2002, 82,569 bacterial blood culture isolates were reported to The Surveillance Network (TSN) Database-USA by 268 laboratories. Susceptibility to relevant antibiotic compounds was analyzed using National Committee for Clinical Laboratory Standards guidelines. RESULTS: Coagulase-negative staphylococci (42.0%), Staphylococcus aureus (16.5%), Enterococcus faecalis (8.3%), Escherichia coli (7.2%), Klebsiella pneumoniae (3.6%), and Enterococcus faecium (3.5%) were the most frequently isolated bacteria from blood cultures, collectively accounting for >80% of isolates. In vitro susceptibility to expanded-spectrum β-lactams such as ceftriaxone were high for oxacillin-susceptible coagulase-negative staphylococci (98.7%), oxacillin-susceptible S. aureus (99.8%), E. coli (97.3%), K. pneumoniae (93.3%), and Streptococcus pneumoniae (97.2%). Susceptibilities to fluoroquinolones were variable for K. pneumoniae (90.3–91.4%), E. coli (86.0–86.7%), oxacillin-susceptible S. aureus (84.0–89.4%), oxacillin-susceptible coagulase-negative staphylococci (72.7–82.7%), E. faecalis (52.1%), and E. faecium (11.3%). Combinations of antimicrobials are often prescribed as empiric therapy for bacteremia. Susceptibilities of all blood culture isolates to one or both agents in combinations of ceftriaxone, ceftazdime, cefepime, piperacillin-tazobactam or ciprofloxacin plus gentamicin were consistent (range, 74.8–76.3%) but lower than similar β-lactam or ciprofloxacin combinations with vancomycin (range, 93.5–96.6%). CONCLUSION: Ongoing surveillance for antimicrobial susceptibility remains essential, and will enhance efforts to identify resistance and attempt to limit its spread. BioMed Central 2004-05-10 /pmc/articles/PMC420484/ /pubmed/15134581 http://dx.doi.org/10.1186/1476-0711-3-7 Text en Copyright © 2004 Karlowsky et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
spellingShingle | Research Karlowsky, James A Jones, Mark E Draghi, Deborah C Thornsberry, Clyde Sahm, Daniel F Volturo, Gregory A Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 |
title | Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 |
title_full | Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 |
title_fullStr | Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 |
title_full_unstemmed | Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 |
title_short | Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 |
title_sort | prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the united states in 2002 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420484/ https://www.ncbi.nlm.nih.gov/pubmed/15134581 http://dx.doi.org/10.1186/1476-0711-3-7 |
work_keys_str_mv | AT karlowskyjamesa prevalenceandantimicrobialsusceptibilitiesofbacteriaisolatedfrombloodculturesofhospitalizedpatientsintheunitedstatesin2002 AT jonesmarke prevalenceandantimicrobialsusceptibilitiesofbacteriaisolatedfrombloodculturesofhospitalizedpatientsintheunitedstatesin2002 AT draghideborahc prevalenceandantimicrobialsusceptibilitiesofbacteriaisolatedfrombloodculturesofhospitalizedpatientsintheunitedstatesin2002 AT thornsberryclyde prevalenceandantimicrobialsusceptibilitiesofbacteriaisolatedfrombloodculturesofhospitalizedpatientsintheunitedstatesin2002 AT sahmdanielf prevalenceandantimicrobialsusceptibilitiesofbacteriaisolatedfrombloodculturesofhospitalizedpatientsintheunitedstatesin2002 AT volturogregorya prevalenceandantimicrobialsusceptibilitiesofbacteriaisolatedfrombloodculturesofhospitalizedpatientsintheunitedstatesin2002 |